MELANIE A LOBEL

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry CHARLESTON, SC NPI 1013033273

General Payments — all program years on this page

$2,692.96

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $683.22 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $683.2217

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $346.0312
Teva Pharmaceuticals USA, Inc. $186.332
Alkermes, Inc. $113.282
Neurocrine BioSciences, Inc. $37.581

By program year

Program yearAmountRecords
2018 $347.9821
2019 $829.0224
2020 $172.645
2021 $193.485
2022 $397.899
2023 $68.734
2024 $683.2217

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078174117 Janssen Pharmaceuticals, Inc $19.84 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174133 Janssen Pharmaceuticals, Inc $21.42 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174167 Janssen Pharmaceuticals, Inc $13.40 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174225 Janssen Pharmaceuticals, Inc $20.38 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174289 Janssen Pharmaceuticals, Inc $20.08 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174321 Janssen Pharmaceuticals, Inc $20.86 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174429 Janssen Pharmaceuticals, Inc $122.82 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174493 Janssen Pharmaceuticals, Inc $12.32 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174557 Janssen Pharmaceuticals, Inc $21.64 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174655 Janssen Pharmaceuticals, Inc $24.17 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174725 Janssen Pharmaceuticals, Inc $25.53 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078174739 Janssen Pharmaceuticals, Inc $23.57 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120543121 Alkermes, Inc. $15.54 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120543123 Alkermes, Inc. $97.74 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150816552 Neurocrine Biosciences, Inc. $37.58 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151536387 Teva Pharmaceuticals USA, Inc. $124.99 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151536487 Teva Pharmaceuticals USA, Inc. $61.34 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.